全球知名监管专家、前BMS集团副总裁 王慧君博士 出任台湾浩鼎CEO
02 juin 2023 03h11 HE
|
OBI Pharma USA
她在制药业成绩显赫; 曾率BMS团队在五大治疗领域，开发九种首创新药在美国成功上市，并推广至世界各地，嘉惠病患无数。 台湾台北, June 02, 2023 (GLOBE NEWSWIRE) --...
OBI Pharma Announces Executive Leadership Management Change – Heidi Wang, Ph.D. Appointed as Chief Executive Officer
02 juin 2023 03h11 HE
|
OBI Pharma Inc.
Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision and to bring innovative cancer therapies to patients globally. She brings a wealth...
SPOK TO PRESENT AT THE INAUGURAL EF HUTTON GLOBAL CONFERENCE
08 mai 2023 09h35 HE
|
Spok Holdings, Inc.
ALEXANDRIA, Va., May 08, 2023 (GLOBE NEWSWIRE) -- via IBN -- Spok Holdings, Inc. (NASDAQ: SPOK) today announced that Vincent D. Kelly, president and chief executive officer, will be presenting at...
Clinical Trial Imaging Market is Growing Rapidly Due to the Increasing Use of Imaging in Clinical Trials to Assess the Efficacy and Safety of Drugs and Medical Devices
27 avr. 2023 10h32 HE
|
Beyond Market Insights
Ottawa, April 27, 2023 (GLOBE NEWSWIRE) -- Beyond Market Insights, a leading market research firm has recently published a comprehensive report on the "Clinical Trial Imaging Market Size, Share,...
OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease
25 avr. 2023 02h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...
Global In-vitro Fertilization Microscopes Market Expected to Generate a Revenue of $250.4 Million and Grow at a Healthy CAGR of 9.4% in the 2022-2031 Timeframe [240-Pages] | Depicted by Research Dive
24 avr. 2023 10h30 HE
|
Research Dive
New York, USA, April 24, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global in-vitro fertilization microscopes market is expected to garner $250.4 million in...
PharmAla Biotech to supply Clinical Psychedelic Lab at Monash University Clinical Trial with LaNeo MDMA
20 avr. 2023 08h00 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech is proud to have been selected as the MDMA manufacturing partner for the Clinical Psychedelic Lab at Monash...
Compass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
19 avr. 2023 08h30 HE
|
Compass Therapeutics
BOSTON, April 19, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules
11 avr. 2023 08h00 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA), a Canadian biotechnology company dedicated to the research and development of...
OBI Pharma Announces Poster Presentations at AACR 2023 Annual Meeting for OBI-999 combination synergy with checkpoint inhibitor as well as Globo H-targeted CAR T-cell immunotherapy
10 avr. 2023 03h00 HE
|
OBI Pharma Inc.
TAIPEI, Taiwan, April 10, 2023 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174) today announced preclinical data demonstrating significant synergistic effects of OBI-999 and pembrolizumab (anti-PD1...